One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

Hugh Pelham discusses research collaboration between LMB and AstraZeneca in more depth

Published on 20 May, 2014

Mike Scialom talks to Sir Hugh Pelham about why pledge from the MRC LMB and AstraZeneca could mean good news for Cambridge. This article is no longer available from the source website: Cambridge News 20 May 2014